COVID-19: FDA authorises Regeneron antibody drug given to Trump

November 2020 Aljazeera; The US Food and Drug Administration (FDA) has granted emergency-use authorisation for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment given to President Donald Trump that he said helped cure him of the disease. The FDA said on Saturday that the monoclonal antibodies, casirivimab and imdevimab, …

Read More »